Skip to content
  • My Cytovance
  • Events
  • Careers
Cytovance Biologics
  • CDMO Services
    • Overview
    • Microbial
    • Mammalian
    • Pre-Commercial and Commercial
    • Support
  • Your Partner
    • Overview
    • Our Team
    • Facilities
  • Knowledge Library
    • Overview
    • Publications
    • Ingenuity Blog
  • Contact Us
  • My Cytovance
  • Events
  • Careers
Cytovance Biologics
  • CDMO Services
    • Overview
    • Microbial
    • Mammalian
    • Pre-Commercial and Commercial
    • Support
  • Your Partner
    • Overview
    • Our Team
    • Facilities
  • Knowledge Library
    • Overview
    • Publications
    • Ingenuity Blog
  • Contact Us
  • Strain Development
  • Microbial Process Development
  • Microbial Analytical Development
  • Microbial Manufacturing

Microbial Process Development

Maximize the Performance of Your Microbial-Based Process

Team Cytovance leverages modern technologies and decades of experience to proactively tackle threats to development in both upstream microbial-based expression and downstream purification. Our goal is to help you get the most from your process and program investment.
A Cytovance scientist working in an microbial process development lab.

Exceptional Process Development

With more than 84 different proteins expressed successfully in the past decade in both E.coli and yeast (Pichia or Saccharomyces) batch and fed-batch fermentation, we can develop robust, large-scale-capable fermentation processes in single-use or stainless-based technologies. Using either the platformed Keystone™ Expression System or custom-engineered solutions for your molecule, in addition to proven soluble and insoluble protein refolding processes, our experienced team can ensure maximal productivity of your microbial process for scale-up.

Client Focused Service with Integrated Analytics

As your responsive CDMO partner, we leverage our experience and capabilities to fit our process to your molecule. From full-service strain and microbial process development or a facilitated timeline with the Cytovance Keystone™ Expression System, we can be flexible to fit your needs. Analytical support from our resourceful lab teams is seamlessly integrated to inform process development decisions and next steps with your dedicated program management team.
Let's Find The Right Process For Your Product
Green Icon of Pichia for microbial CDMO services from Cytovance Biologics.

Ingenuity That Reduces Unpredictability

It takes skill and expertise to navigate a microbial molecule from concept to development. Through our experience in establishing the KeystoneTM Expression System and moving dozens of microbial projects to cGMP manufacturing, we have gained a thorough understanding of critical parameters in the microbial development process that can reduce unpredictability and increase productivity at a larger scale. With our Keystone™ Expression System coupled with our fermentation, refold, downstream and analytical expertise, we keep your molecule moving forward and provide immediate solutions if surprises occur.

State of the Art Upstream and Downstream Capabilities

Being a leader in microbial-based recombinant protein manufacturing means that we have access to state-of-the-art technologies in both development and manufacturing. From small-scale Design of Experiment (DOE) based fermentation studies to progressive scale-up, we only utilize the latest harvest, purification, and analytical technologies from Beckman, Thermo Fisher Scientific, and other trusted brands, to enable the development of robust, large-scale microbial-based manufacturing processes.

Related Areas of Expertise

Strain Development

Customized E.coli, Yeast, and Pichia strain development strategies. 

Learn More

Microbial Analytical Development

Robust analytical development personalized for your drug substance or biologic.

Learn More

Microbial Manufacturing

Benefit from our full-service cGMP facility with up to 1,000L microbial capacity.

Learn More

Contact Us

We’re Ready to Learn About Your Project

Meet Team Cytovance in 2026!

  • – BIO Investment and Growth Summit: March 2-3, Miami Beach, FL
  • – OPCU Large Molecule: March 24, Virtual
  • – World Vaccine Congress: March 30-April 2, Washington D.C. | Booth 536
    –
    PEGS: May 11-15, Boston, MA 
  • – TIDES USA Oligonucleotide & Peptide Therapeutics: May 11-14, Boston, MA 
  • – BIO International Convention: June 22-25, San Diego, CA | Booth 4445 
  • – BioProcess International East: September 22-25, Boston, MA 
  • – CPHI Europe: October 6-8, Milan, Italy 
  • – CDMO Live Americas: October 19-21, Boston, MA 
  • – OPCU Large Molecule: October 27, Virtual
Subscribe to our Newsletter
Unlock Ingenuity Here

Vision Statement

We believe in a healthier world where every biologic’s path to commercialization is advanced by a development and manufacturing partner that delivers ingenuity end-to-end.

  • CDMO Services
  • Your Partner
  • Knowledge Library
  • Careers
  • Contact Us

© 2026 Cytovance Biologics